Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Ruiz

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Journal of Chemical Information and Modeling|July 22, 2020
DIA-DB: A Database and Web Server for the Prediction of Diabetes DrugsHoracio Pérez-Sánchez, Helena den-Haan, Jorge Peña-García, et al.
Cancers|September 9, 2022
Cancer Histology and Natural History of Patients with Lung Cancer and Venous ThromboembolismPedro Ruiz-Artacho, Ramón Lecumberri, Javier Trujillo-Santos, et al.
BMC Nephrology|November 7, 2022
Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING studyDomingo Hernández, Teresa Vázquez-Sánchez, Eugenia Sola, et al.
The European Respiratory Journal|August 13, 2021
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolismDavid Jiménez, Carmen Rodríguez, Francisco León, et al.
Epilepsia|January 29, 2013
Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic optionBelén Pérez, Luis González Gutiérrez-Solana, Alfonso Verdú, et al.
Journal of Clinical Medicine|July 9, 2020
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-AnalysisJorge García-González, Juan Ruiz-Bañobre, Francisco J Afonso-Afonso, et al.
Journal of Clinical Medicine|May 5, 2021
Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant RecipientsDomingo Hernández, Teresa Vázquez, Juana Alonso-Titos, et al.
Journal of Clinical Medicine|June 2, 2021
Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant PatientsDomingo Hernández, Juana Alonso-Titos, Teresa Vázquez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitabilityJonathan R Roth, Travis Rush, Samantha J Thompson, et al.
Human Mutation|January 23, 2014
Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patientsAngels García-Cazorla, Alfonso Oyarzabal, Joana Fort, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Journal of Chemical Information and Modeling|July 22, 2020
DIA-DB: A Database and Web Server for the Prediction of Diabetes DrugsHoracio Pérez-Sánchez, Helena den-Haan, Jorge Peña-García, et al.
Cancers|September 9, 2022
Cancer Histology and Natural History of Patients with Lung Cancer and Venous ThromboembolismPedro Ruiz-Artacho, Ramón Lecumberri, Javier Trujillo-Santos, et al.
BMC Nephrology|November 7, 2022
Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING studyDomingo Hernández, Teresa Vázquez-Sánchez, Eugenia Sola, et al.
The European Respiratory Journal|August 13, 2021
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolismDavid Jiménez, Carmen Rodríguez, Francisco León, et al.
Epilepsia|January 29, 2013
Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic optionBelén Pérez, Luis González Gutiérrez-Solana, Alfonso Verdú, et al.
Journal of Clinical Medicine|July 9, 2020
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-AnalysisJorge García-González, Juan Ruiz-Bañobre, Francisco J Afonso-Afonso, et al.
Journal of Clinical Medicine|May 5, 2021
Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant RecipientsDomingo Hernández, Teresa Vázquez, Juana Alonso-Titos, et al.
Journal of Clinical Medicine|June 2, 2021
Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant PatientsDomingo Hernández, Juana Alonso-Titos, Teresa Vázquez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitabilityJonathan R Roth, Travis Rush, Samantha J Thompson, et al.
Human Mutation|January 23, 2014
Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patientsAngels García-Cazorla, Alfonso Oyarzabal, Joana Fort, et al.
Pageof 21